These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

31 related articles for article (PubMed ID: 10905877)

  • 1. Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group.
    Poynard T; McHutchison J; Goodman Z; Ling MH; Albrecht J
    Hepatology; 2000 Jan; 31(1):211-8. PubMed ID: 10613748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.
    Glue P; Rouzier-Panis R; Raffanel C; Sabo R; Gupta SK; Salfi M; Jacobs S; Clement RP
    Hepatology; 2000 Sep; 32(3):647-53. PubMed ID: 10960463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatitis C: therapeutic perspectives].
    Trépo C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B297-302. PubMed ID: 12180304
    [No Abstract]   [Full Text] [Related]  

  • 4. New proposal for response-guided peg-interferon-plus-ribavirin combination therapy for chronic hepatitis C virus genotype 2 infection.
    Abe H; Aida Y; Ishiguro H; Yoshizawa K; Seki N; Miyazaki T; Itagaki M; Sutoh S; Ika M; Kato K; Shimada N; Tsubota A; Aizawa Y
    J Med Virol; 2013 Sep; 85(9):1523-33. PubMed ID: 23775277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience in complex therapy ribavine chronic viral hepatitis C].
    Domashenko OM
    Lik Sprava; 2011; (3-4):101-3. PubMed ID: 22416372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: viral dynamics, viral levels at certain time points, or a combination of both?
    Weiland O
    J Hepatol; 2009 Jul; 51(1):4-7. PubMed ID: 19446915
    [No Abstract]   [Full Text] [Related]  

  • 8. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with ronkoleukin and alfaferon combination in complex chronic hepatitis C treatment].
    Popova LL; Suzdal'tsev AA; Konstantinov DIu; Golik OO; Vasil'ev SIu
    Eksp Klin Gastroenterol; 2011; (6):102-7. PubMed ID: 22168088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment for chronic hepatitis C, more opportunity, more challenge].
    Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of chronic hepatitis C: interferon alpha-2b alone or in combination with ribavirin].
    Fontaine H; Pol S
    Gastroenterol Clin Biol; 1999 Apr; 23(4):541-4. PubMed ID: 10416124
    [No Abstract]   [Full Text] [Related]  

  • 12. [When standard therapy fails. New therapy options in chronic hepatitis C].
    MMW Fortschr Med; 2001 Jan; 143(3):53-4. PubMed ID: 11215347
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical utility of early viral load quantification.
    Colucci G
    Hepatology; 2000 Jul; 32(1):158. PubMed ID: 10905877
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice].
    Dou XG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678
    [No Abstract]   [Full Text] [Related]  

  • 16. Biochemical and virological changes in serum of nonresponder or relapser chronic hepatitis C patients retreated with interferon and ribavirin followed by interferon alone.
    Cuccorese G; Tursi A; Spinazzola AM; Modeo ME; Miglietta A
    Am J Gastroenterol; 2000 Sep; 95(9):2399-400. PubMed ID: 11007262
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.